2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine has been researched along with Glioma in 1 studies
2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine: a selective inhibitor of nitric oxide synthase; structure given in first source
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Oyoshi, T | 1 |
Nomoto, M | 1 |
Hirano, H | 1 |
Kuratsu, J | 1 |
1 other study available for 2-amino-5,6-dihydro-6-methyl-4h-1,3-thiazine and Glioma
Article | Year |
---|---|
Pathodynamics of nitric oxide production within implanted glioma studied with an in vivo microdialysis technique and immunohistochemistry.
Topics: Animals; Brain Neoplasms; Enzyme Inhibitors; Glioma; Half-Life; Immunohistochemistry; Male; Microdia | 2003 |